IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS.

Launched by FEDERAL UNIVERSITY OF SÃO PAULO · Dec 10, 2023

Keywords

ClinConnect Summary

The clinical trial titled "IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS" is looking at how a special nutritional supplement called ImmuneRecov® can help people who are experiencing lingering health issues after having COVID-19. Many patients struggle with problems like weakened lung function and muscle strength for months after their illness. This study aims to see if taking ImmuneRecov® for 30 days can improve these symptoms, helping participants breathe easier and regain strength.

To be eligible for this trial, participants need to have had a confirmed COVID-19 diagnosis that required hospitalization and must be classified as having moderate illness, which means they have signs of lung issues but are still able to breathe without extra oxygen. The trial is currently recruiting individuals aged 65 to 74, and both men and women can participate. Those who have been out of the hospital for more than 14 days or who have started exercising or taking other supplements are not eligible. Participants can expect to take the supplement for a month and help contribute to important research that could improve recovery for many others affected by Long COVID.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: The inclusion criteria encompassed post-COVID-19 patients with a confirmed COVID-19 diagnosis through a positive RT-PCR test, who also required hospitalization, meeting the criteria for moderate severity classification as defined by the World Health Organization (WHO). In summary, according to the WHO, moderate illness is characterized by individuals who exhibit signs of lower respiratory disease during clinical assessment or imaging and maintain an oxygen saturation level (SpO2) of ≥94% while breathing room air at sea level.
• • Exclusion Criteria: Exclusion criteria included individuals discharged from the hospital for more than 14 days and those who initiated physical activity or began taking any dietary supplements or vitamins.